It is thus imperative to evaluate the diagnostic accuracy of PAI‐1 and TAFI and its relation to glycemic control among T2DM patients as failure to timely detect the changes in fibrinolysis predisposes to thromboembolism, which increases mortality in these patients. The gene discussed is SERPINE1; the disease is type 2 diabetes mellitus.